191 related articles for article (PubMed ID: 35121743)
1. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.
Manley SJ; Olou AA; Jack JL; Ruckert MT; Walsh RM; Eades AE; Bye BA; Ambrose J; Messaggio F; Anant S; VanSaun MN
Cell Death Dis; 2022 Feb; 13(2):114. PubMed ID: 35121743
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1/2 cells through the adenosine monophosphate‑activated protein kinase signaling pathway.
Wang SJ; Lu WY; Liu KY
Mol Med Rep; 2017 Nov; 16(5):7163-7169. PubMed ID: 28901521
[TBL] [Abstract][Full Text] [Related]
3. Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
Sci Rep; 2021 Feb; 11(1):2923. PubMed ID: 33536560
[TBL] [Abstract][Full Text] [Related]
4. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
5. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
6. The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells.
Grandhaye J; Hmadeh S; Plotton I; Levasseur F; Estienne A; LeGuevel R; Levern Y; Ramé C; Jeanpierre E; Guerif F; Dupont J; Froment P
Mol Cell Endocrinol; 2021 Jan; 520():111080. PubMed ID: 33189865
[TBL] [Abstract][Full Text] [Related]
7. The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.
Nicolas S; Rochet N; Gautier N; Chabry J; Pisani DF
Metabolism; 2020 Feb; 103():154027. PubMed ID: 31778708
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
Akimoto M; Maruyama R; Kawabata Y; Tajima Y; Takenaga K
Cell Death Dis; 2018 Jul; 9(8):804. PubMed ID: 30038429
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
Ramzan AA; Bitler BG; Hicks D; Barner K; Qamar L; Behbakht K; Powell T; Jansson T; Wilson H
Mol Cell Biochem; 2019 Nov; 461(1-2):37-46. PubMed ID: 31292831
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice.
Balasubramanian P; Schaar AE; Gustafson GE; Smith AB; Howell PR; Greenman A; Baum S; Colman RJ; Lamming DW; Diffee GM; Anderson RM
Elife; 2022 Mar; 11():. PubMed ID: 35297761
[TBL] [Abstract][Full Text] [Related]
11. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.
Wang Y; Liang B; Lau WB; Du Y; Guo R; Yan Z; Gan L; Yan W; Zhao J; Gao E; Koch W; Ma XL
Autophagy; 2017; 13(11):1855-1869. PubMed ID: 28825851
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin Receptor Agonist, AdipoRon, Causes Vasorelaxation Predominantly Via a Direct Smooth Muscle Action.
Hong K; Lee S; Li R; Yang Y; Tanner MA; Wu J; Hill MA
Microcirculation; 2016 Apr; 23(3):207-20. PubMed ID: 26728950
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
[TBL] [Abstract][Full Text] [Related]
14. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin Enhances Fatty Acid Signaling in Human Taste Cells by Increasing Surface Expression of CD36.
Lin F; Liu Y; Rudeski-Rohr T; Dahir N; Calder A; Gilbertson TA
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982874
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin receptor agonist AdipoRon modulates human and mouse platelet function.
Zhou XH; Cheng ZP; Lu M; Lin WY; Luo LL; Ming ZY; Hu Y
Acta Pharmacol Sin; 2023 Feb; 44(2):356-366. PubMed ID: 35918410
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
Lindfors S; Polianskyte-Prause Z; Bouslama R; Lehtonen E; Mannerla M; Nisen H; Tienari J; Salmenkari H; Forsgård R; Mirtti T; Lehto M; Groop PH; Lehtonen S
Diabetologia; 2021 Aug; 64(8):1866-1879. PubMed ID: 33987714
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.
Kim Y; Park CW
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974901
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of AdipoRon on the liver of Huoyan goose fed a high-fat diet.
Cao Z; Ma B; Cui C; Zhao J; Liu S; Qiu Y; Zheng Y; Gao M; Luan X
Poult Sci; 2022 Apr; 101(4):101708. PubMed ID: 35150940
[TBL] [Abstract][Full Text] [Related]
20. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
